Vascular Wall Maturation and Prolonged Angiogenic Effect by Endothelial-Specific Platelet-Derived Growth Factor Expression
Authors:
- Keren LevanonKLKeren Levanon
- Nira Varda-BloomNVNira Varda-Bloom
- Shoshana GreenbergerSGShoshana Greenberger
- Iris BarshackIBIris Barshack
- Iris GoldbergIGIris Goldberg
- Arie OrensteinAOArie Orenstein
- Eyal BreitbartEBEyal Breitbart
- Aviv ShaishASAviv Shaish
- Dror HaratsDHDror Harats
- 1 November 2006
- journal article
- Published by S. Karger AG in Pathobiology
- Vol. 73 (3) , 149-158
Abstract
Background: The implementation of angiogenic gene therapy at clinics is hindered by the transience of the therapeutic effect. Recruiting vascular wall smooth muscle cells, a process termed ‘maturation’, can stabilize newly formed vessels. Objective: To induce angiogenesis followed by vessel maturation in a murine ischemic limb model by endothelial cell-specific promoter regulated expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor-BB (PDGF-BB). Methods: We constructed adenoviral vectors containing angiogenic factors VEGF and PDGF-B regulated by a modified preproendothelin-1 (PPE-1-3x) promoter and investigated their angiogenic effect in a murine ischemic limb model. Results: VEGF gene therapy increased perfusion and the vessel density in the limb shortly after expression with PPE-1-3x promoter or cytomegalovirus (CMV) promoter vectors, but only PPE-1-3xVEGF treatment exhibited a sustained effect. Expression of PDGF-B by PPE-1-3x promoter resulted in morphological maturation of the vasculature and further increased the perfusion, while nonspecific expression of PDGF-B with CMV promoter had no therapeutic effect. Regulation of dual therapy with VEGF and PDGF-B by PPE-1-3x promoter resulted in an early-onset, sustained angiogenic effect accompanied by vessel maturation. Conclusions: Systemic gene therapy with the angiogenic factors VEGF and PDGF-B under angiogenic- endothelial cell-specific regulation was effective in inducing functionally and morphologically mature vasculature.Keywords
This publication has 39 references indexed in Scilit:
- Stabilized HIF‐1α is superior to VEGF for angiogenesis in skeletal muscle via adeno‐associated virus gene transferThe FASEB Journal, 2005
- Phase I Trial to Evaluate the Safety of H5.020CMV.PDGF-b and Limb Compression Bandage for the Treatment of Venous Leg Ulcer: Trial AHuman Gene Therapy, 2004
- Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Angiogenesis imaging – ultrasoundBritish Journal of Radiology, 2003
- Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcersExpert Opinion on Biological Therapy, 2002
- α5 and α2 Integrin Gene Transfers Mimic the PDGF-B–Induced Transformed Phenotype of Fibroblasts in Human SkinLaboratory Investigation, 2001
- Tissue-specific gene therapy directed to tumor angiogenesisGene Therapy, 2001
- Platelet‐derived growth factor‐B increases colon cancer cell growth in vivo by a paracrine effectJournal of Cellular Physiology, 1995
- Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter.Journal of Clinical Investigation, 1995
- Migratory and proliferative effect of platelet‐derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet‐derived growth factorJournal of Cellular Physiology, 1994